Sabra Healthcare REIT Inc. (NASDAQ:SBRA) dropped 2.1% during mid-day trading on Wednesday . The stock traded as low as $22.75 and last traded at $22.93, with a volume of 238,063 shares trading hands. The stock had previously closed at $23.41.

SBRA has been the subject of several research analyst reports. TheStreet upgraded shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating in a research report on Tuesday, August 2nd. BTIG Research started coverage on shares of Sabra Healthcare REIT in a research report on Thursday, August 25th. They set a “neutral” rating for the company. JMP Securities reissued a “hold” rating on shares of Sabra Healthcare REIT in a research note on Friday, September 9th. Cantor Fitzgerald reissued a “buy” rating on shares of Sabra Healthcare REIT in a research note on Friday, August 19th. Finally, Citigroup Inc. lifted their price target on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 17th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and five have assigned a buy rating to the stock. Sabra Healthcare REIT currently has an average rating of “Hold” and a consensus price target of $23.18.

The company has a market cap of $1.52 billion, a price-to-earnings ratio of 27.75 and a beta of 1.20. The stock’s 50-day moving average price is $24.72 and its 200 day moving average price is $22.00.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/sabra-healthcare-reit-inc-sbra-trading-down-2-1.html

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Monday, August 1st. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.58 by $0.03. The company earned $74.20 million during the quarter, compared to the consensus estimate of $56.04 million. Sabra Healthcare REIT had a return on equity of 6.27% and a net margin of 24.63%. Sabra Healthcare REIT’s revenue was up 31.1% on a year-over-year basis. During the same period last year, the company earned $0.53 earnings per share. On average, analysts predict that Sabra Healthcare REIT Inc. will post $2.29 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 31st. Stockholders of record on Monday, August 15th were given a dividend of $0.42 per share. The ex-dividend date was Thursday, August 11th. This represents a $1.68 annualized dividend and a dividend yield of 7.23%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 202.41%.

Several hedge funds have recently added to or reduced their stakes in the company. BlackRock Institutional Trust Company N.A. increased its stake in Sabra Healthcare REIT by 2.8% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 2,218,952 shares of the company’s stock valued at $44,579,000 after buying an additional 59,712 shares during the period. Leisure Capital Management increased its stake in Sabra Healthcare REIT by 9.6% in the second quarter. Leisure Capital Management now owns 197,235 shares of the company’s stock valued at $4,070,000 after buying an additional 17,301 shares during the period. BlackRock Inc. increased its stake in Sabra Healthcare REIT by 9.5% in the first quarter. BlackRock Inc. now owns 62,840 shares of the company’s stock valued at $1,262,000 after buying an additional 5,433 shares during the period. Aperio Group LLC increased its stake in Sabra Healthcare REIT by 71.7% in the first quarter. Aperio Group LLC now owns 22,370 shares of the company’s stock valued at $449,000 after buying an additional 9,343 shares during the period. Finally, Copeland Capital Management LLC increased its stake in Sabra Healthcare REIT by 39.7% in the second quarter. Copeland Capital Management LLC now owns 584,325 shares of the company’s stock valued at $12,058,000 after buying an additional 165,973 shares during the period. Institutional investors and hedge funds own 92.14% of the company’s stock.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company owns and invests in real estate serving the healthcare industry. The Company’s segment is investments in healthcare-related real estate properties. Its primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

5 Day Chart for NASDAQ:SBRA

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.